Search Engine Optimization Company and SEO Services - Real SEO Firm

Vivisimo releases Cluster Med™

Vivisimo announces the release of Cluster Med™, a powerful research tool that allows biomedical and life sciences researchers to search the MedLine database far more productively and efficiently.

ClusterMed(TM) organizes the long list of results returned by PubMed(R) into hierarchical folders allowing researchers to hone in on the most relevant results quickly.

By organizing results into categories, users discover the main themes relating to the subject of the query and can easily reach relevant articles buried deep in the chronological list. In addition, similar articles are grouped together, rather than scattered throughout the results.

Using ClusterMed(TM), drug discovery researchers save mission-critical research time and discover insights that previously required long hours of browsing through results. Results can be organized by author or source allowing researchers to customize their queries based on their research needs. This feature can also profile the research specialties of an author or institution. For additional flexibility, results can be clustered by date of publication or MeSH headings.

The enormous amount of information being produced today by the life sciences industry requires new, sophisticated tools to help users synthesize that information into timely, actionable knowledge. "Imagine intelligently organizing in seconds -- under your control -- all the PubMed research literature on a specific topic," stated Don Taylor, Senior Director, Life Sciences Solutions, Vivisimo. "For example, searching PubMed for 'apoptosis and breast cancer' returns 2,536 articles in a chronological, one dimensional list.

ClusterMed enlivens this unwieldy list into meaningful, hierarchical folders in which PubMed article number 1,432 may appear within a ClusterMed folder just 2 clicks away. We expect ClusterMed to swiftly become the most affordable, mission-critical knowledge management tool in the industry."

ClusterMed builds upon Vivisimo's extensive experience with several of the largest pharmaceutical firms, Journal of Biological Chemistry, JAMA, NEJM, BMJ, PNAS, and other top biomedical journals and societies and is currently in trials at several life sciences companies.

A free demonstration of the product is available at http://www.clustermed.info

Source: Vivisimo

Posted by nakul at March 31, 2004 11:34 PM | TrackBack